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Abstract
Background: Areca nut chewing has been reported to be associated with obesity, metabolic syndrome,
hypertension, and cardiovascular mortality in previous studies. The aim of this study was to examine whether
chewing areca nut increases the risk of coronary artery disease (CAD) in Taiwanese men.
Methods: This study is a hospital-based case-control study. The case patients were male patients diagnosed in Taiwan
between 1996 and 2009 as having a positive Treadmill exercise test or a positive finding on the Thallium-201 single-
photon emission computed tomography myocardial perfusion imaging. The case patients were further evaluated by
coronary angiography to confirm their CAD. Obstructive CAD was defined as a ≥ 50% decrease in the luminal diameter
of one major coronary artery. The patients who did not fulfill the above criteria of obstructive CAD were excluded.
The potential controls were males who visited the same hospital for health check-ups and had a normal
electrocardiogram but no history of ischemic heart disease or CAD during the time period that the case patients
were diagnosed. The eligible controls were randomly selected and frequency-matched with the case patients
based on age. Multiple logistic regression analyses were used to estimate the odds ratio of areca nut chewing and
the risk of obstructive CAD.
Results: A total of 293 obstructive CAD patients and 720 healthy controls, all men, were analyzed. Subjects who
chewed areca nut had a 3.5-fold increased risk (95% CI = 2.0-6.2) of having obstructive CAD than those without,
after adjusting for other significant covariates. The dose-response relationship of chewing areca nut and the risk of
obstructive CAD was also noted. After adjusting for other covariates, the 2-way additive interactions for obstructive
CAD risk were also significant between areca nut use and cigarette smoking, hypertension and dyslipidemia.
Conclusions: Long-term areca nut chewing was an independent risk factor of obstructive CAD in Taiwanese men.
Interactive effects between chewing areca nut and cigarette smoking, hypertension, and dyslipidemia were also
observed for CAD risk. Further exploration of their underlying mechanisms is necessary.
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Background
Ischemic heart disease, including coronary artery disease
(CAD), is the leading cause of death worldwide [1].
CAD patients have a high risk of myocardial infarction,
heart failure, angina pectoris, stroke, and even sudden
cardiac death [2]. In Taiwan, cardiovascular disease was
the second leading cause of death after cancer in 2010.
Cardiovascular disease accounted for 10.8% of the total
deaths in the Taiwanese population [3].
Areca nut chewing is the fourth most popular sub-
stance abuse habit in the world [4]. Previous studies have
found that chewing areca nut is associated with obesity,
metabolic syndrome, hypertension (HTN), and all-cause
mortality [5-9]. A few epidemiological studies also linked
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[9-11]. Although those studies were conducted in the
community, their diagnosis of cardiovascular disease was
based on a questionnaire or the report of the Interna-
tional Classification of Disease, Ninth Revision (ICD-9)
codes 390-459. These codes were not reconfirmed by car-
diologists and likely introduced random misclassification
of the outcome of interest. In addition, the exposure of
interest (areca nut chewing) was also collected from a
non-validated questionnaire. Since the habit of chewing
areca nut is prevalent in Taiwanese men, we used the
accurate method of diagnosed obstructive CAD to
further examine the relationships between areca nut
chewing and the risk of CAD in a Taiwanese male
population.
Methods
Study population
This study is a hospital-based case-control study. The
case patients were male patients diagnosed as having a
positive treadmill exercise test or a positive finding on
the Thallium-201 (Tl-201) single-photon emission com-
puted tomography (SPECT) myocardial perfusion ima-
ging (MPI) at the Kaohsiung Medical University Hospital
(KMUH), a medical center in the southern Taiwan,
between 1996 and 2009. The positive Treadmill exercise
test was defined as an ST segment elevation or depres-
sion ≥ 1 mm in three consecutive beats in ≥ 2c o n s e c u -
tive leads. A positive finding on the Tl-201 SPECT MPI
was defined as reversible defects in at least one vascular
territory. Case patients were also performed a coronary
angiography (CAG) using the Judkins technique. Then,
the angiograms were analyzed by two experienced cardi-
ologists who were blinded to the results of the question-
naire. The severity of stenosis was assessed by the
quantitative coronary angiography (Infinix, Celeve CBi-
BP, XTP-8100 G/DFP-8000D, Toshiba Medical Systems
Corp) of the major coronary arteries and their major
branches. Obstructive CAD was defined as a ≥ 50%
decrease in the luminal diameter of one major coronary
artery [12,13]. If an artery had more than one significant
stenosis, we analyzed only the most severe lesion. In the
cases of discrepancies between the two cardiologists, a
third cardiologist was consulted to determine the final
diagnosis. Case patients who did not fulfill the above cri-
teria were diagnosed as having non-obstructive CAD
(n = 30) and were excluded from the study.
The potential controls were males who visited the same
hospital for health check-ups during the same time per-
iod as the case patients. The potential controls had a nor-
mal electrocardiogram record during their examination
and did not have any history of ischemic heart disease or
CAD. The eligible controls were randomly selected and
frequency-matched with the case patients based on age
(≤ 40, 41-60, and > 60 years old). In total, 293 case
patients and 720 healthy controls were included in this
study. This study was approved by the ethics committee
of KMUH, and all study subjects provided written
informed consent.
Questionnaire
A standardized questionnaire was used by a well trained
research assistant to interview study subjects. The ques-
tionnaire collected detailed information about the sub-
jects’ demographic characteristics and history of using
three major substances (cigarette smoking, alcohol con-
sumption, and areca nut chewing). The detailed informa-
tion has been described elsewhere [14,15]. In brief,
cigarette smokers were defined as regular consumers of
10 cigarettes or more per day for > 6 months. Alcohol
drinkers were defined as regular consumers of alcoholic
drinks more than once a week for > 6 months. Areca nut
chewers were defined as regular consumers of one or
more pieces of areca nut per day for > 6 months. If the
study subject was a regular substance user, then detailed
questions about the time of start and quit, daily amount
used, and type of consumption were also collected.
Former users were those who had stopped using the sub-
stance for ≥ 1 year.
Two kinds of chewing areca nut commonly used in Tai-
wan were also included on the questionnaire: Lao-hwa
and betel leaf. The composite of the Lao-hwa regimen
includes areca nut, betel palm inflorescence, and slaked
lime, whereas the composite of betel leaf regimen includes
areca nut, betel leaf, and slaked lime [16].
The items on the questionnaire regarding the use of
these three major substances were validated in our pre-
vious study [14,15]. In brief, we used different biomarkers
in different specimens to verify information about cigarette
smoking, alcohol, and areca nut chewing from question-
naire [14]. For verifying areca nut chewing, since areca
nuts in Taiwan contain a high concentration of safrole, a
carcinogen, our research collaborators analyzed safrole-
DNA adducts using the P-postlabelling method in 47 tis-
sue specimens of esophageal cancer (16 areca chewers and
31 non-areca chewers by questionnaire). Safrole-DNA
adducts were detected in 5 (31.3%) out of 16 areca
chewers and, in contrast, detected in none of the 31 non-
areca chewers (Fischer’s exact test, p = 0.0028) [14].
We quantified the cumulative amount of substance
use by “drink-years” for alcohol consumption and “pack-
years” for cigarette smoking and areca nut chewing. The
number of “drink-years” and “pack-years” were calcu-
lated by multiplying the amount of the substances con-
sumed per day, such as 15.75 g-alcohol drinks (one
~350 cc bottle of beer with 4.5% alcohol concentration),
20-cigarette packs or 10-areca nut packs, by the years of
substance use.
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(HTN), diabetes mellitus (DM), dyslipidemia, stroke,
CAD, and arrhythmia were also recorded. HTN was
defined as having a history of HTN or anti-HTN drug
use. DM was defined as having a history of DM, using
an oral glucose-lowering agent or insulin, or having a
fasting blood sugar greater than 126 mg/dL. Dyslipide-
mia was defined as having a history of dyslipidemia,
using a lipid-lowering agent or having an abnormal high
level of plasma cholesterol (>200 mg/dL) during health
exams.
Statistical analysis
Demographic characteristics, histories of substance use
and prevalence of disease were compared between healthy
controls and case patients (obstructive CAD patients) by
Chi-Square test or Fisher’s exact test when appropriate.
Because our main study aim was to investigate whether
chewing areca nut is a risk factor for CAD, we used
unconditional logistic regression to analyze the effect of
different levels of areca nut use on CAD risk, after adjust-
ing for other covariates that were statistically significant in
the crude analyses. These covariates included body mass
index (BMI), educational level, age, cigarette smoking,
alcohol consumption, DM, HTN, and dyslipidemia.
To assess the interactive effect of areca nut use and
other main risk factors (cigarette smoking, DM, HTN, or
dyslipidemia) for CAD among subjects, Rothman’s syner-
gism index (SI) was used to assess the empirical deviation
from the additive interaction relation [17]. A computed
SI value that departed from the expected additive null
was considered to be an additive interaction effect. The
ORs and their variance-covariance matrix were used to
calculate values of SI and their 95% CIs [17]. Statistical
significance was defined by a p value less than 0.05. All
statistical analyses were carried out by using SAS soft-
ware (version 8.0; SAS Institute Inc, Cary, NC).
Results
The percentages of CAD patients in the ≤ 40, 41-60,
and > 60 year old age groups were 3.4% (10/293), 37.2%
(109/293) and 59.4% (174/293), respectively. These per-
centages were similar to those of the healthy controls.
Compared to healthy controls, the obstructive CAD
patient groups had a significantly higher percentage of
DM, HTN, dyslipidemia, cigarette smoking, and areca
nut chewing. In addition, obstructive CAD patients were
less educated, and more likely to be obese than the
healthy controls (Table 1).
After adjusting for age, educational levels, BMI, DM,
HTN, dyslipidemia, cigarette smoking, and alcohol con-
sumption, subjects who had ever chewed areca nut had
an increasing risk (adjusted OR = 3.5, 95% CI = 2.0-6.2)
of having obstructive CAD (Table 2). The significant
results were similar in both former and current areca nut
users. A dose-response relationship between cumulative
areca nut exposure and obstructive CAD risk was also
noted. Subjects who chewed Lao-hwa had a relatively
higher risk of obstructive CAD (adjusted OR = 5.1; 95%
CI = 1.9-13.6), compared to those chewing betel leaf
(adjusted OR = 2.7; 95% CI = 1.3-5.7) (Table 2).
Because most of the male subjects who chewed areca
nut also smoked cigarettes in Taiwan, we further
Table 1 Comparison of demographic and clinical
characteristics in study subjects
Parameter Healthy
control
Obstructive
CAD
p value
a
Total 720 293
Age (yrs)
≤ 40 30 (4.2) 10 (3.4) 0.063
41-60 321 (44.6) 109 (37.2)
> 60 369 (51.2) 174 (59.4)
Educational levels < 0.001
< High school 131 (18.2) 89 (30.4)
High school 312 (43.3) 123 (42.0)
> High school 277 (38.5) 81 (27.6)
BMI < 0.001
≤ 18.5 19 (2.6) 5 (1.7)
18.5-27 591 (82.1) 197 (67.2)
> 27 110 (15.3) 91 (31.1)
DM < 0.001
No 638 (88.6) 178 (60.8)
Yes 82 (11.4) 115 (39.2)
HTN < 0.001
No 576 (80.0) 74 (25.3)
Yes 144 (20.0) 219 (74.7)
Dyslipidemia < 0.001
No 610 (84.7) 89 (30.4)
Yes 110 (15.3) 204 (69.6)
Cigarette smoking (pack-years) < 0.001
Never user 414 (57.5) 76 (25.9)
User 306 (42.5) 217 (74.1)
1-20 133 (18.5) 63 (21.5)
> 20 173 (24.0) 154 (52.6)
Alcohol consumption (drink-years) 0.078
Never user 518 (71.9) 191 (65.2)
User 202 (28.1) 102 (34.8)
1-20 100 (13.9) 46 (15.7)
> 20 102 (14.2) 56 (19.1)
Areca nut chewing (pack-years) < 0.001
Never user 663 (92.1) 205 (70.0)
User 57 (7.9) 88 (30.0)
1-20 34 (4.7) 30 (10.2)
> 20 23 (3.2) 58 (19.8)
BMI, body mass index; CAD, coronary artery disease; CI, confidence interval;
DM, diabetes mellitus; HTN, hypertension;
aChi-Square test or Fisher’s exact test when appropriate
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who smoked cigarettes. Compared to male subjects who
only smoked cigarettes, those who both regularly
s m o k e da n dc h e w e da r e c an u t sh a d2 . 2 -( 9 5 %C I=1 . 1 -
5.0) and 8.0-fold higher risks (95% CI = 3.6-17.9) of
CAD for 1-20 pack-years and > 20 pack-years of areca
nut chewing, respectively (Additional file 1: Table S1).
The 2-way synergistic effects between areca nut chewing
and cigarette smoking, DM, HTN, and dyslipidemia on
CAD risk among the subjects were evaluated in additive
interaction models (Table 3). The expected OR were 4.3,
5.2, 11.9, and 15.9 when regarding the joint effects for
combining areca nut using with smoking, DM, HTN and
dyslipidemia for CAD, respectively. Based on the model of
addictive scale, significant additive effects of areca nut
chewing on CAD risk were found with cigarette smoking,
HTN, and dyslipidemia (SI = 4.3 (95% CI = 1.3-13.7), 4.1
(95% CI = 1.7-9.7) and 2.9 (95% CI = 1.1-7.7) respectively).
Besides uses of areca nut, the variables of DM, HTN, dysli-
pidemia and smoking were also the important risk factors
of CAD in this study (Additional file 2: Table S2 and Addi-
tional file 3: Table S3).
Discussion
The present study mainly found that chewing areca nut
increased the risk of obstructive CAD in Taiwanese men,
particularly among subjects who smoked cigarettes. Sev-
eral previous studies have reported the association
between areca nut chewing and the risk of cardiovascular
diseases in Taiwan [8-10,18]. Although two of the four
epidemiological studies were prospective cohort designs
[8,10], their exposure and outcome of interest were from
a questionnaire and ICD-9 codes, respectively, neither of
which were validated by the authors. In addition, a vari-
ety of cardiovascular diseases, such as hypertensive heart
disease, cardiomyopathy, ischemic heart disease and
arrhythmia, were included and analyzed as the same dis-
ease in these studies.
L a ne ta l .f i r s tr e p o r t e dt h a ti na ne l d e r l yp o p u l a t i o n ,
people who ever chewed areca nut were at a higher risk
of all-cause (hazard ratio (HR) = 1.19, 95% CI: 1.05, 1.35)
and cerebrovascular disease mortality (HR = 1.66, 95%
CI: 1.19, 2.30), compared with those who never chewed
areca nut [8]. In the same year, Guh et al. found that the
OR for prevalent heart disease and a betel-quid con-
sumption rate of 10 times/day was 1.37 (95% CI = 1.1-
1.6) among women [18]. Subsequently, a study conducted
by Lin et al. also found that former and current betel nut
chewers had an increased risk for cardiovascular and all-
cause mortality [9]. The former betel nut chewers had
adjusted relative risk (RR) 1.56 (95% CI = 1.02-2.38) and
1.40 (95% CI = 1.17-1.68) for CVD and all-cause mortal-
ity respectively, when compared with never chewer. The
current chewers had RR 2.02 (95% CI = 1.31-3.13) and
1.40 (95% CI = 1.16-1.70) for CVD and all-cause mortal-
ity respectively, when compared with never chewer. Yen
Table 2 Odds ratio for obstructive coronary artery disease associated with areca nut use
Total Healthy controls
(n = 720)
Obstructive CAD
(n = 293)
Crude OR (95% CI) Adjusted OR (95% CI)
a
N (%) N (%)
Areca nuts
Never-user 663 (92.1) 205 (70.0) 1.0 1.0
User 57 (7.9) 88 (30.0) 5.9 (3.5-7.2) 3.5 (2.0-6.2)
Former user 34 (4.7) 69 (23.5) 2.6 (1.4-5.0) 3.0 (1.3-7.6)
Current user 23 (3.2) 19 (6.5) 6.6 (4.2-10.2) 3.8 (2.0-7.2)
Daily uses (pieces/day)
1-20 37 (5.1) 36 (12.3) 3.1 (1.9-5.1) 2.0 (1.0-3.9)
> 20 20 (2.8) 52 (17.7) 8.4 (4.9-14.4) 7.5 (3.4-16.5)
Cumulative uses
(pack-years)
1-20 34 (4.7) 30 (10.2) 2.9 (1.7-4.8) 2.0 (1.0-4.2)
> 20 23 (3.2) 58 (19.8) 8.2 (4.9-13.6) 6.1 (2.9-12.7)
Type of uses
b,
Betel leaf 36 (5.0) 36 (12.3) 3.2 (2.0-5.3) 2.7 (1.3-5.7)
Lao-hwa 11 (1.5) 26 (8.9) 7.6 (3.7-15.7) 5.1 (1.9-13.6)
Both
c 7 (1.0) 23 (7.8) 10.6 (4.5-25.1) 3.7 (1.3-10.8)
BMI, body mass index; CAD, coronary artery disease; CI, confidence interval; OR, odds ratio;
aAdjusting for diabetes, hypertension, dyslipidemia, alcohol drink, cigarette smoking, age, educational levels, and BMI
bSix missing data
c Lao-hwa and Betel leaf
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between chewing betel nut and an increasing risk of inci-
dent CVD among men [10]. The betel-quid ever chewers
were at higher risk of CVD (HR = 1.24, 95% CI = 1.11-
1.39) when compared with never chewer.
To minimize outcome misclassification, the present
study used CAG to confirm the diagnosis of obstructive
CAD. In addition, the exposure of interest (areca nut
chewing) in this study was validated in our previous
research [14]. The prevalence of areca nut chewing was
7.9% in the control group in our study, which was com-
patible with the corresponding figures (~10%) in the
previous survey [19].
We also found a dose-dependent relationship between
areca nut chewing and CAD risk, as a higher amount of
areca nut chewing was associated with a higher risk of
obstructive CAD. The additive interactions in the risk of
obstructive CAD between “areca nut chewing and cigar-
ette smoking,”“ areca nut chewing and HTN” and “areca
nut chewing and dyslipidemia” were also observed. CAD,
which is similar to other atherosclerotic diseases, has
been previously associated with risk factors such as DM,
HTN, dyslipidemia, age and obesity [20]. Areca nut
chewing has been previously reported to be associated
with many risk factors of CAD. In one study, general and
central obesity were related to areca nut chewing in Chi-
nese males [5]. Areca nut chewing has also been asso-
ciated with HTN in Taiwanese patients with type-2 DM
[7]. The association between metabolic syndrome and
areca nut chewing has also been reported [6,21]. Indians
living in the United Kingdom were found to have high
incidences of cardiovascular disease, HTN and late onset
diabetes [22]. Those findings, along with ours, suggest
that areca nut might act as an independent risk factor for
CAD or as a mediator that modifies the risk of HTN or
dyslipidemia.
The present study found that the Lao-hwa regimen was
more potent than the betel leaf regimen by comparing the
ORs for their associations with obstructive CAD. Betel leaf
may have some beneficial effects for cardiovascular disease
through its vasorelaxation, antioxidant effects and inhibi-
tion of platelet aggregation [23-27], which is consistent
with our clinical findings.
There are several possible mechanisms to explain the
link between areca nut chewing, CAD and atherosclerosis.
Atherosclerosis, especially CAD, was related to chronic
inflammation in previous studies [20,28]. Arecoline, the
most well-known content of the areca nut, was reported
to induce COX-2 up-regulation and higher TIMP expres-
sion in in-vitro studies [29,30]. Hydroxychavicol, another
Table 3 The additive interaction between conventional risk factors and areca nuts use for coronary artery disease
Factors/Category Healthy controls (n = 720)
N (%)
Obstructive CAD
(n = 293)
N (%)
Adjusted OR (95% CI)
c Additive interaction
a,b
EOR
a SI
b (95% CI)
Smoke/Areca nuts use
Never/Never 410 (56.9) 73 (24.9) 1.0
Ever/Never 253 (35.1) 132 (45.1) 3.8 (2.4-6.1)
Never/Ever 4 (0.6) 3 (1.0) 1.5 (0.2-13.5)
Ever/Ever 53 (7.4) 85 (29.0) 15.0 (7.8-28.9) 4.3 4.3 (1.3-13.7)
Diabetes/Areca nuts use
Never/Never 591 (82.1) 128(43.7) 1.0
Ever/Never 72 (10.0) 77 (26.3) 2.6 (1.5-4.3)
Never/Ever 47 (6.5) 50 (17.1) 3.6 (1.9-6.9)
Ever/Ever 10 (1.4) 38 (12.9) 10.4 (4.1-26.3) 5.2 2.2 (0.7-6.8)
Hypertension/Areca nuts use
Never/Never 528(73.3) 51(17.4) 1.0
Ever/Never 135(18.8) 154(52.6) 9.7 (6.0-15.6)
Never/Ever 48 (6.7) 23 (7.8) 3.2 (1.5-6.5)
Ever/Ever 9 (1.3) 65 (22.2) 45.5 (19.0-109.2) 11.9 4.1 (1.7-9.7)
Dyslipidemia/Areca nuts use
Never/Never 560(77.8) 53(18.1) 1.0
Ever/Never 103(14.3) 152(51.9) 13.0 (8.2-20.6)
Never/Ever 50 (6.9) 36 (12.3) 3.9 (2.0-7.5)
Ever/Ever 7 (1.0) 52 (17.7) 44.4 (17.1-115.2) 15.9 2.9 (1.1-7.7)
BMI, body mass index; CAD, coronary artery disease; CI, confidence interval; OR, odds ratio;
aExpected odds ratios estimated based on additive interaction models.
bSynergism index estimated by an additive interaction model.
cOdds ratios were adjusted
for age, educational levels, BMI, alcohol drinking, and diabetes, hypertension, dyslipidemia, or cigarette smoking
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induce reactive oxygen species production via redox
cycling [31], increase superoxide dismutase activity in
mice liver [32] and reduce glutathione in cell line studies
[33,34]. One study, done by Lee et al., reported that betel-
quid could increase PKC and NF-B expressions in mice
[35]. Subsequently, Ni et al. found that human buccal
mucosa cells exposed to areca nut could activate NF-B
expression [36]. The expressions of tumor necrosis factor-
alpha, interleukin (IL)-1 beta, IL-6 and IL-8 were also
increased in human peripheral blood mononuclear cells
after being treated with areca nut extract [37]. The
extracts of areca nut, piper inflorescence and betel quid
were found to enhance the cytotoxic effects of oxidized
low-density lipoprotein (LDL) toward bovine aortic
endothelial cells [23]. Because cigarette smoking might
enhance the oxidation of LDL cholesterol and lead to
atherosclerosis, the enhancement of cytotoxic effects of
oxidized LDL by arecoline might explain the additive
effect of areca nut chewing and smoking on the risk of
CAD.
There were several limitations in the study. The
healthy controls were drawn from healthy volunteers
attending general health check-ups; thus, this group may
not be representative of the general population. The
detailed lifestyle information about vegetable consump-
tion and exercise status was not routinely collected in
our questionnaire, which might influence the risk of
CAD studied here.
Conclusions
In conclusion, we have shown that long-term areca nut
chewing is an independent risk factor of CAD in Taiwa-
nese men, especially among subjects who smoke cigarettes.
A dose-response effect of areca nut chewing in relation to
the risk of CAD was also found in this study. There is an
additive effect of areca nut chewing and cigarette smoking,
HTN, and dyslipidemia on the risk of CAD. Further stu-
dies are needed to clarify the mechanisms of areca nut
chewing leading to CAD.
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